FDA Inaction on Hair Loss Drug’s Suicide Risk Sparks Lawsuit
The lawsuit seeks to force the FDA to act on a 4-year-old petition calling for removal of the popular hair loss drug from the market over risks that include depression and suicidal ideation. Medscape Medical News
Read more